The CEO who built Exelixis and reshaped Biogen now wants to lead a nine-figure IPO for San Francisco's Vir Bio.

source https://finance.yahoo.com/m/06eb4b07-46c7-3ff1-9d79-9f89449b3a3d/biotech-vet-george-scangos.html?.tsrc=rss